2.
Tumor type | Molecues | Body fluid | Markers | Application | Reference |
Prostate cancer | Protein | Urine | β-catenin | Screening | [44] |
Prostate cancer | miRNA | Plasma, serum, urine | 4 miRNAs | Diagnosis, prognosis | [45] |
Prostate cancer | Vesicles | Plasma | Microvesicle number | Diagnosis, prognosis | [46] |
Ovarian cancer | Protein | Serum | exosomal antigen | Diagnosis | [47] |
Ovarian cancer | miRNA | Serum | 12 miRNAs | Screening | [48] |
Lung cancer | Protein | Pleural effusion | 3 proteins | Diagnosis | [49] |
Lung squamous cell carcinoma |
miRNA | Plasma | 5 miRNAs | Monitor | [50] |
Lung adenocarcinoma cancer |
miRNA | Plasma | 10 miRNAs | Screening | [51] |
GBM | miRNA | Serum | 3 miRNAs | Diagnosis | [52] |
Breast Cancer | miRNA | Serum | 3 miRNAs | Diagnosis | [53] |
Pancreatic cancer | mRNA | Saliva | 7 mRNAs | Diagnosis | [54] |
Colon cancer | Protein | Ascites | Claudin-3 | Diagnosis | [55] |
Melanoma | Protein | Plasma | Caveolin-1 | Diagnosis, prognosis | [56] |
Gastric cancer | Vesicle | Plasma | EVs concentration | Diagnosis | [57] |
Bladder Cancer | Protein | Serum | EPS812, mucin-4 | Diagnosis | [58] |
Cervical cancer | miRNA | Cervical lavage fluid | miR-21, miR-146a | Diagnosis | [59] |
Acute lymphoma | miRNA | Plasma | miR-92 | Diagnosis | [60] |
Liver cancer | Vesicles | Serum | Microvesicle number | Diagnosis | [61] |